Series Preferred Conversion Rate. The conversion rate in effect at any time for conversion of the Series Preferred (the “Series Preferred Conversion Rate”) shall be the quotient obtained by dividing the applicable Original Issue Price of such series of Series Preferred by the applicable Series Preferred Conversion Price, calculated as provided in Section 4(c), then in effect for such series of Series Preferred being converted.
Appears in 3 contracts
Samples: License Agreement (Mirum Pharmaceuticals, Inc.), License Agreement (Mirum Pharmaceuticals, Inc.), License Agreement (Lumena Pharmaceuticals, Inc.)
Series Preferred Conversion Rate. The conversion rate in effect at any time for conversion of the Series Preferred (the “"Series Preferred Conversion Rate”") shall be the quotient obtained by dividing the applicable Original Issue Price of such series of the Series Preferred by the applicable "Series Preferred Conversion Price, ," calculated as provided in Section 4(c), then in effect for such series of Series Preferred being converted.
Appears in 1 contract
Series Preferred Conversion Rate. The conversion rate in effect at any time for conversion of the Series Preferred (the “Series Preferred Conversion Rate”) shall be the quotient obtained by dividing the applicable Original Issue Price of such series of the Series Preferred by the applicable “Series Preferred Conversion Price, ,” calculated as provided in Section 4(c5(c), then in effect provided that for such series purposes of Section 5(h), the Original Issue Price of the Series C-3 Preferred being convertedStock shall be deemed to be the Original Issue Price of the Series C-2 Preferred Stock.
Appears in 1 contract
Samples: Subordination Agreement (Revance Therapeutics, Inc.)